These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

67 related articles for article (PubMed ID: 2864063)

  • 21. Celiprolol--new therapeutic horizons in beta blockade. Proceedings of a workshop. Tarrytown, New York, 16 January 1985.
    Br J Clin Pract Suppl; 1985 Jun; 40():1-100. PubMed ID: 2864055
    [No Abstract]   [Full Text] [Related]  

  • 22. New beta-adrenergic blockers.
    Lowenthal DT
    Am Fam Physician; 1980 Aug; 22(2):142-3. PubMed ID: 6105818
    [No Abstract]   [Full Text] [Related]  

  • 23. Effect of beta-blockade on right ventricular performance in patients with and without right ventricular dysfunction due to coronary artery disease.
    Singh A; Alpert MA; Sanfelippo JF; Mukerji V; Villarreal D; Holmes RA; Sunderrajan EV; Morgan RJ
    Arch Intern Med; 1986 Nov; 146(11):2135-9. PubMed ID: 2877643
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Celiprolol: an investigation of a new beta 1-, alpha 2-adrenoceptor antagonist in asthmatic patients.
    Rosenthal RR; Doshan HD; Applin WJ; Caruso FS
    Br J Clin Pract Suppl; 1985 Jun; 40():34-6. PubMed ID: 2864060
    [No Abstract]   [Full Text] [Related]  

  • 25. The antagonist and partial beta agonist properties of celiprolol in isolated rat cardiac tissue.
    Smith RD; Cobuzzi A; Wolf PS; Pruss TP
    Res Commun Chem Pathol Pharmacol; 1986 Feb; 51(2):147-61. PubMed ID: 2870551
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The effects of the beta-adrenoceptor blocking agent, celiprolol, on blood lipids.
    Hitzenberger G
    Br J Clin Pract Suppl; 1985 Jun; 40():85-7. PubMed ID: 2864072
    [No Abstract]   [Full Text] [Related]  

  • 27. The effect of celiprolol on peripheral circulation in healthy volunteers.
    Ehringer H; Konecny U; Rasser W
    Br J Clin Pract Suppl; 1985 Jun; 40():91-9. PubMed ID: 2864073
    [No Abstract]   [Full Text] [Related]  

  • 28. [Numerous indications in cardiology. Beta receptor blockers can never be overlooked].
    MMW Fortschr Med; 2005 May; 147(18):57. PubMed ID: 15934594
    [No Abstract]   [Full Text] [Related]  

  • 29. Metoprolol reduces 'compensatory' coronary blood flow following occlusion of an adjacent branch without altering post-occlusion hyperaemia.
    Ványi J; Roy Parratt J; Végh A
    Life Sci; 2006 Apr; 78(20):2384-90. PubMed ID: 16297410
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Celiprolol: A new dimension in beta blockade. Based upon a symposium. Milan, Italy, June 13, 1985.
    J Cardiovasc Pharmacol; 1986; 8 Suppl 4():S1-152. PubMed ID: 2427834
    [No Abstract]   [Full Text] [Related]  

  • 31. [Treatment of coronary heart disease with the beta-1-receptor blocker celiprolol in a long-term study over a 12-month period].
    Klinger D
    Wien Med Wochenschr; 1987 Jun; 137(12):278-86. PubMed ID: 2887073
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Contrasting actions of celiprolol and metoprolol on cardiac performance in normal volunteers.
    Silke B; Thompson A; Riddell JG
    Cardiovasc Drugs Ther; 1997 Mar; 11(1):57-61. PubMed ID: 9140679
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Celiprolol: its profile as a potential antiarrhythmic agent.
    Pruss TP
    Am Heart J; 1988 Nov; 116(5 Pt 2):1412-5. PubMed ID: 2461069
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Clinical perspective on celiprolol: cardioprotective potential.
    Frishman WH
    Am Heart J; 1991 Feb; 121(2 Pt 2):724-9. PubMed ID: 1671192
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Adrenoceptor blocking agents. Compounds related to metoprolol.
    Lövgren K; Hedberg A; Nilsson JL
    J Med Chem; 1981 Apr; 24(4):451-4. PubMed ID: 6115060
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Influence of chronic exposure to high concentrations of D-glucose and long-term beta-blocker treatment on intracellular calcium concentrations of porcine aortic endothelial cells.
    Salameh A; Dhein S
    Diabetes; 1998 Mar; 47(3):407-13. PubMed ID: 9519747
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Esmolol during cardiopulmonary bypass.
    Abramson DC; Pivalizza EG; Mehlhorn U
    Anesth Analg; 1995 Aug; 81(2):429-30. PubMed ID: 7618750
    [No Abstract]   [Full Text] [Related]  

  • 38. [Effects of metoprolol and alprenolol on the carbohydrate and lipid metabolism during beta adrenergic stimulation with isoproterenol in the normal subject].
    Zilker T; Schnelle A; Schinz A; Klein G; Bottermann P
    Verh Dtsch Ges Inn Med; 1978; (84):1163-5. PubMed ID: 741917
    [No Abstract]   [Full Text] [Related]  

  • 39. [Cardioprotective and membrane effects of exaprolol].
    Cesk Fysiol; 1986; 35(5):478-80. PubMed ID: 2903800
    [No Abstract]   [Full Text] [Related]  

  • 40. Effects of the serotonin-antagonist ketanserin on the function of ischaemic and normally perfused myocardium and modification by beta-1-blockade in anaesthetized normotensive dogs.
    Schad H; Heimisch W; Barankay A; Hesse S; Mendler N
    J Cardiothorac Anesth; 1989 Oct; 3(5 Suppl 1):2. PubMed ID: 2520957
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.